Microarray studies and database analysis have suggested in melanoma a co-expressed upregulation of α9-nAChR and PD-L1, a protein overexpressed in melanoma cells and involved in in the regulation of EMT, cancer stemness, tumor development, metastasis formation, and resistance to therapy [127]. The gene discussed is CD274; the disease is melanoma.